Skip to content
⌘KStart free
AI InfrastructureDefenseQuantumAll studies →

XBRANE.ST SE Equity

Xbrane Biopharma AB
Nasdaq Stockholm+ CompareTear sheet →
Unclassified · FY ends Dec 31
SEK 9.66
-0.32 (-3.21%)
SEK · as of 2026-08-18 · marketstack
Documents (DOC)Legal & controls (LGCT)

Events

all filings market-wide (EVX) →
0 8-K filings · 0 13D · 0 13G
DateEventWhat happened / filerSource
No 8-K or Schedule 13D/G filings on record for XBRANE.ST in the collected window (US SEC filers only).
Source: SEC EDGAR (public domain)

Every row is a filed document, checked against its EDGAR index.

Related →Filings market-wide (EVX)Red flags (FLAG)Documents (DOC)Legal & controls (LGCT)